These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8152581)

  • 21. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
    Price DL; Borchelt DR; Sisodia SS
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease.
    Gregory CA; Hodges JR
    J Neural Transm Suppl; 1996; 47():103-23. PubMed ID: 8841959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
    Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
    Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dementia of frontal lobe type.
    Neary D; Snowden JS; Northen B; Goulding P
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):353-61. PubMed ID: 3258902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical picture of frontal lobe degeneration of non-Alzheimer type.
    Gustafson L
    Dementia; 1993; 4(3-4):143-8. PubMed ID: 8401782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontal lobe degeneration of non-Alzheimer type.
    Gustafson L; Brun A; Passant U
    Baillieres Clin Neurol; 1992 Nov; 1(3):559-82. PubMed ID: 1344203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum.
    Mak K; Yang F; Vinters HV; Frautschy SA; Cole GM
    Brain Res; 1994 Dec; 667(1):138-42. PubMed ID: 7895077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
    Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
    Neurosci Lett; 1997 Apr; 226(1):65-7. PubMed ID: 9153643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia.
    Nyatsanza S; Shetty T; Gregory C; Lough S; Dawson K; Hodges JR
    J Neurol Neurosurg Psychiatry; 2003 Oct; 74(10):1398-402. PubMed ID: 14570833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.
    Dermaut B; Kumar-Singh S; De Jonghe C; Cruts M; Löfgren A; Lübke U; Cras P; Dom R; De Deyn PP; Martin JJ; Van Broeckhoven C
    Brain; 2001 Dec; 124(Pt 12):2383-92. PubMed ID: 11701593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emergence of the frontal lobe and its morbidity, as opposed to the central lobe.
    Brun A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():3-5. PubMed ID: 10436332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of dementias and implications for therapy.
    Roy OW; Cohen NR; Nicoll JA
    Indian J Pathol Microbiol; 2005 Jul; 48(3):289-99. PubMed ID: 16761736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches for prion and Alzheimer's diseases.
    Wisniewski T; Sigurdsson EM
    FEBS J; 2007 Aug; 274(15):3784-98. PubMed ID: 17617224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease.
    Guerrero-Muñoz MJ; Castillo-Carranza DL; Krishnamurthy S; Paulucci-Holthauzen AA; Sengupta U; Lasagna-Reeves CA; Ahmad Y; Jackson GR; Kayed R
    Neurobiol Dis; 2014 Nov; 71():14-23. PubMed ID: 25134727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration.
    Brun A; Liu X; Erikson C
    Neurodegeneration; 1995 Jun; 4(2):171-7. PubMed ID: 7583681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.